All In Biotech

Drug Trial Radar · NCT00072839

Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease

A Pilot Study of the Safety and Efficacy of ALX-0600 in Subjects With Moderately Active Crohn's Disease

Last checked: Nov 19, 2026Latest source record: May 25, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

100

Actual

Start

Nov 12, 2003

Primary completion

Jul 28, 2005

Study completion Jul 28, 2005

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Nov 13, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to determine whether an investigational compound, ALX-0600, is safe and effective in treating Crohn's Disease.

Conditions

  • Crohn's Disease

Interventions

  • ALX-0600Drug

    teduglutide

  • placeboDrug

    placebo solution injected subcutaneously

  • teduglutide 0.05Drug

    0.05 mg/jg/d subcutaneous daily injection into thigh or abdomen

  • teduglutide 0.2 mgDrug

    0.2 mg/kg/d subcutaneously injected into thigh or abdomen

  • Teduglutide 0.05 doseDrug

    0.05 mg/kg/d subcutaneous daily injection into thigh or abdomen

  • teduglutide 0.1 mg doseDrug

    0.1 mg/kg/d daily subcutaneous injection into thigh or abdomen

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The primary efficacy variable is the percentage of subjects who respond to treatment, defined as the percentage of subjects who are in remission (CDAI less than 150) or have a 100-point or greater reduction from baseline in CDAI score at dosing Week 8.Time frame: 8 weeks of treatment

Locations

26 sites in 2 countries. Site status is shown where the registry gives one.

  • Advanced Clinical Therapeutics

    Tucson, Arizona

  • Rocky Mountain Gastroenterology

    Lakewood, Colorado

  • Rx Trials

    Washington D.C., District of Columbia

  • Clinical Trials Management of Boca Raton

    Boca Raton, Florida

  • Clinical Research of West Florida

    Clearwater, Florida

  • Venture Research

    North Miami Beach, Florida

  • Visions Clinical Research - Sarasota

    Sarasota, Florida

  • Emory University School of Medicine

    Atlanta, Georgia

  • Pinnacle Trials

    Atlanta, Georgia

  • Saint Joseph's Health System

    Atlanta, Georgia

  • Northwestern University School of Medicine

    Chicago, Illinois

  • University of Chicago

    Chicago, Illinois

  • University of Louisville

    Louisville, Kentucky

  • Long Island Clinical Research Associates

    Great Neck, New York

  • Asher Kornbluth, MD, PC

    New York, New York

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • Allegheny General Hospital-Allegheny Ctr for Digestive Diseases

    Pittsburgh, Pennsylvania

  • Methodist Hospital/Baylor University

    Houston, Texas

  • University of Utah

    Salt Lake City, Utah

  • McGuire DVAMC

    Richmond, Virginia

  • Dean Foundation Research Center

    Madison, Wisconsin

  • Vancouver General Hospital

    Vancouver, British Columbia, Canada

  • Odyssey Research

    Victoria, British Columbia, Canada

  • Health Sciences Center

    Winnipeg, Manitoba, Canada

  • Queen Elizabeth II Health Sciences

    Halifax, Nova Scotia, Canada

  • Life Screening Centres

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.